Search

Fariba A Aria

from San Jose, CA
Age ~70
Get Report
Also known as:
Fariba Z Aria, Fariba A Mortezaei, Fariva A Aria, Fariba Ariya, Fariba I
Phone and address:
2338 Ruby Ave, San Jose, CA 95148
(408) 841-9182
Related to:
Larry S Perez, 40Arash Aria, 38Bahram Aria, 79Aria Mitra, 72Reza Z Mortezaei, 69Shahab Mortezaei, 40Shahram AriaArmin Aria, 34Mahmood D Aria, 52Shahram Aria, 64
Connected to:
Anna Aria, 74Jason T Aria, 40Marie G Aria, 35Melvin A Aria, 87Nina P Aria, 63Sandra S Aria, 69Melda K Ariadno, 56Amanda E Ariagno, 43Scott R Ariagno, 50Anne L Arian, 74

Fariba Aria Phones & Addresses

  • 2338 Ruby Ave, San Jose, CA 95148 (408) 841-9182
  • 21810 Almaden Ave, Cupertino, CA 95014
  • North Hollywood, CA
  • Santa Clara, CA
  • Madison, WI
  • Cleveland, OH

Business Records

Name / Title
Company / Classification
Phones & Addresses
Fariba Aria
President, Owner
Kimia Corp
Chemicals
2102 Walsh Ave #B, Santa Clara, CA 95050
2102-B Walsh Ave, Santa Clara, CA 95050
(408) 748-1046, (408) 748-0846
Fariba Aria
AVANT-GARDE PATENTS LTD

Publications

Us Patents

Compositions And Methods For Treating Angiogenesis-Related Diseases, Wounds And Cosmetic Use Of Components Of , And Methods Of Preparation Thereof

View page
US Patent:
7927634, Apr 19, 2011
Filed:
Apr 13, 2010
Appl. No.:
12/758863
Inventors:
Hui Zhao - Santa Paula CA, US
Krzysztof Bojanowski - Santa Paula CA, US
Fariba Aria - Cupertino CA, US
Reza Mortezaei - Cupertino CA, US
Assignee:
Sunny Biodiscovery, Inc. - Santa Paula CA
International Classification:
A61K 36/00
A61L 15/16
US Classification:
424725, 424446, 424447
Abstract:
Compositions and methods for treating angiogenesis-related diseases and for skin care in mammals is disclosed that includes, as an active pharmaceutical agent, an effective amount of purified extract from , or a fraction or a lyophilizate thereof, or one or more active component contained in said extract.

Composition Comprising Threitol Phosphate And Salts Thereof

View page
US Patent:
8236784, Aug 7, 2012
Filed:
Nov 17, 2009
Appl. No.:
12/620138
Inventors:
Hui Zhao - Santa Paula CA, US
Krzysztof Bojanowski - Santa Paula CA, US
Fariba Aria - Cupertino CA, US
Reza Mortezaei - Cupertino CA, US
Assignee:
Sunny Biodiscovery, Inc. - Santa Paula CA
International Classification:
A61K 31/66
A61K 31/6615
A61K 8/55
C07F 9/09
A61P 17/00
A61P 19/00
A61Q 11/00
A61Q 19/00
A61Q 19/08
US Classification:
514103, 514106, 514129, 424 59, 424 62
Abstract:
This application discloses compositions containing synthetic threitol phosphates, in particular threitol monophosphate, threitol-bis-phosphate, threitol diphosphate, and/or threitol triphosphate. The threitol phosphates are useful in treating wounds, for cosmetic applications, and for bone and periodontal regeneration.

Compositions And Methods For Treating Angiogenesis-Related Diseases, Wounds And Cosmetic Use Of Components Of Angelica Sinensis, And Methods Of Preparation Thereof

View page
US Patent:
20060068032, Mar 30, 2006
Filed:
Sep 24, 2004
Appl. No.:
10/948590
Inventors:
Hui Zhao - Fremont CA, US
Krzysztof Bojanowski - Fremont CA, US
Fariba Aria - Cupertino CA, US
Reza Mortezaei - Cupertino CA, US
Assignee:
Sunny BioDiscovery, Inc. - Santa Clara CA
International Classification:
A61K 36/232
A61K 38/18
US Classification:
424725000, 514002000
Abstract:
Compositions and methods for treating angiogenesis-related diseases and for skin care in mammals is disclosed that includes, as an active pharmaceutical agent, an effective amount of purified extract from , or a fraction or a lyophilizate thereof, or one or more active component contained in said extract.

19-Nor-Vitamin D Compounds

View page
US Patent:
56167440, Apr 1, 1997
Filed:
May 23, 1995
Appl. No.:
8/447795
Inventors:
Hector F. DeLuca - Deerfield WI
Heinrich K. Schnoes - Madison WI
Fariba Aria - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07C40100
US Classification:
552653
Abstract:
A 19-nor intermediate compound of the formula ##STR1## where R is the sidechain of a vitamin D derivative and where X. sub. 1 and X. sub. 2 are hydrogen or a hydroxy protecting group. The compounds are used in the preparation of 19-nor-vitamin D end products.

Intermediates In The Preparation Of 19-Nor Vitamin D Compounds

View page
US Patent:
55257453, Jun 11, 1996
Filed:
Mar 27, 1995
Appl. No.:
8/410858
Inventors:
Hector F. DeLuca - Deerfield WI
Heinrich K. Schnoes - Madison WI
Fariba Aria - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07C40100
US Classification:
552653
Abstract:
The invention describes intermediates for use in the synthesis of 1. alpha. -hydroxy-19-nor-vitamin D compounds. The intermediates have the following formula: ##STR1## The disclosed process includes (a) the construction of a 5,8-diol-6-yne intermediate by joining ring-A and ring-C/D portions of the desired end product via the condensation of an acetylenic derivative containing the C/D-ring portion of the desired end product with a cyclic dihydroxy ketone representing the A-ring of the desired end product; (b) the partial reduction of the 6,7 acetylenic triple bond linkage between the A and C/D ring portions to obtain a 5,8-diol-6-ene intermediate; and (c) the reductive removal of the 5,8-oxygen functions to generate the required 5,7-diene end product from which the desired 7-trans(7E)-isomer is purified directly, or after optional double bond isomerization of the 7-cis(7Z)-isomer employing a novel thiophenol-promoted isomerization step.

Preparation Of 19-Nor Vitamin D Compounds

View page
US Patent:
54301963, Jul 4, 1995
Filed:
Sep 8, 1994
Appl. No.:
8/302399
Inventors:
Hector F. DeLuca - Deerfield WI
Heinrich K. Schnoes - Madison WI
Fariba Aria - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07C 4302
C07C 3524
US Classification:
568665
Abstract:
A synthesis of 1. alpha. -hydroxy-19-nor-vitamin D compounds comprises (a) the construction of a 5,8-diol-6-yne intermediate by joining ring-A and ring-C/D portions of the desired end product via the condensation of an acetylenic derivative containing the C/D-ring portion of the desired end product with a cyclic dihydroxy ketone representing the A-ring of the desired end product; (b) the partial reduction of the 6,7 acetylenic triple bond linkage between the A and C/D ring potions to obtain a 5,8-diol-6-ene intermediate; and (c) the reductive removal of the 5,8-oxygen functions to generate the required 5,7-diene end product from which the desired 7-trans(7E)-isomer is purified directly, or after optional double bond isomerization of the 7-cis(7Z)-isomer employing a novel thiophenol-promoted isomerization step.

Preparation Of 19-Nor Vitamin D Compounds

View page
US Patent:
55999581, Feb 4, 1997
Filed:
May 23, 1995
Appl. No.:
8/448115
Inventors:
Hector F. Deluca - Deerfield WI
Heinrich K. Schnoes - Madison WI
Fariba Aria - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07C40100
US Classification:
552653
Abstract:
A synthesis of 1. alpha. -hydroxy-19-nor-vitamin D compounds comprises (a) the construction of a 5,8-diol-6-yne intermediate by joining ring-A and ring-C/D portions of the desired end product via the condensation of an acetylenic derivative containing the C/D-ring portion of the desired end product with a cyclic dihydroxy ketone representing the A-ring of the desired end product; (b) the partial reduction of the 6,7 acetylenic triple bond linkage between the A and C/D ring portions to obtain a 5,8-diol-6-ene intermediate; and (c) the reductive removal of the 5,8-oxygen functions to generate the required 5,7-diene end product from which the desired 7-trans(7E)-isomer is purified directly, or after optional double bond isomerization of the 7-cis(7Z)-isomer employing a novel thiophenol-promoted isomerization step.

Acetylenic Cyclohexane Triol Derivatives

View page
US Patent:
54881838, Jan 30, 1996
Filed:
May 23, 1995
Appl. No.:
8/448105
Inventors:
Hector F. DeLuca - Deerfield WI
Heinrich K. Schnoes - Madison WI
Fariba Aria - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07C 3508
C07F 708
US Classification:
568828
Abstract:
A synthesis of 1. alpha. -hydroxy-19-nor-vitamin D compounds comprises (a) the construction of a 5,8-diol-6-yne intermediate by joining ring-A and ring-C/D portions of the desired end product via the condensation of an acetylenic derivative containing the C/D-ring portion of the desired end product with a cyclic dihydroxy ketone representing the A-ring of the desired end product; (b) the partial reduction of the 6,7 acetylenic triple bond linkage between the A and C/D ring portions to obtain a 5,8-diol-6-ene intermediate; and (c) the reductive removal of the 5,8-oxygen functions to generate the required 5,7-diene end product from which the desired 7-trans(7E)-isomer is purified directly, or after optional double bond isomerization of the 7-cis(7Z)-isomer employing a novel thiophenol-promoted isomerization step.
Control profile
Fariba A Aria from San Jose, CA, age ~70 Get Report